ArticleEuropean journal of histochemistry : EJH2026
Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells.
Yinping Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.